Ireland-based GH Research has just raised $125 million in an oversubscribed Series B financing round.
Mydecine Announces Launch of Cutting-Edge Therapeutic Compound Screening
Mydecine commences screening psilocybin-based drug candidates.
Uber Will ‘Absolutely’ Explore Marijuana Deliveries When Federal Prohibition Ends, CEO Says
The CEO of Uber said on Monday that the ride share company will “absolutely” explore adding marijuana deliveries to its services when federal prohibition ends.
Cybin Advances IND-Enabling Studies of Two Psychedelic Molecules, CYB003 and CYB004 for Investigational New Drug Applications
Cybin prepares two drug candidates, CYB003 and CYB004 for Investigational New Drug applications.
Breaking News: MINDCURE (CSE: MCUR | OTC: MCURF) Announces Partnership with Speak Ai to Enhance iSTRYM, the Company’s Psychedelic Digital Therapeutics Technology Platform
Utilizing Speak Ai’s technology, iSTRYM will provide-AI-driven intelligence to help therapists identify the most efficient and efficacious outcomes for patients of psychedelic assisted psychotherapy
Implantable gold sensor can help monitor vital values, drug effectiveness
Scientists at Johannes Gutenberg University Mainz have developed an implantable sensor based on color-stable gold nanoparticles.
This could push gold price to $1,800 next week
Gold has a chance to break above its key resistance level of $1,750 an ounce next week.
Peter Thiel-Backed Psychedelics Firm Buys Majority of Brain-Control Interface Firm
ATAI Life Sciences, a biosciences company backed by venture capitalist and freedom-loving billionaire Peter Thiel that specializes in experimental treatment of mental disorders with psychedelic drugs, has bought out a majority stake in a company working to meld the mind with machines.
A woman cured her chronic skin itching with weed and didn't need her steroid medications anymore, case report shows
A 60-something woman with skin so itchy it caused her to scratch until she created lesions finally found relief from using cannabis.
How Cannabis Became the Gateway Drug…For Psychedelic Drug Normalization
Forty years ago, cannabis was labelled "a Gateway Drug" to harder drug use -- such as psychedelics. Today, cannabis is the Gateway Drug to psychedelics legalization.
London copper picks up on weak dollar, U.S. infrastructure plans
Copper prices in London rose on Thursday, buoyed by a weakening dollar and hopes of a pick-up in metals demand from a $2 trillion infrastructure proposal in the United States.
Gold's bull market endures, just watch this ratio - Bloomberg Intelligence
The bottom in the gold price will be marked by the crude oil prices peaking, which is the most likely outcome, according to Bloomberg Intelligence.
